Lista de obras -

A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo

artículo científico publicado en 2015

A method for identification of HIV gp140 binding memory B cells in human blood

artículo científico publicado en 2008

A robust pipeline for rapid production of versatile nanobody repertoires

artículo científico publicado en 2014

Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient

artículo científico publicado en 2015

Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity

artículo científico publicado en 2010

Antibodies in HIV-1 vaccine development and therapy

artículo científico publicado en 2013

Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike

artículo científico publicado en 2014

Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG Binding ⬇️

artículo científico publicado el 6 de junio de 2012

Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors

artículo científico publicado en 2008

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

artículo científico publicado en 2009

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein

artículo científico publicado en 2012

Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus

artículo científico publicado en 2012

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission

artículo científico publicado en 2013

CD4-binding-Site Recognition by VH1-46 Germline-derived HIV-1 Neutralizers.

artículo científico publicado en 2014

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

artículo científico publicado en 2012

Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs.

artículo científico publicado en 2013

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

artículo científico publicado en 2016

Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells

artículo científico publicado en 2011

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies

artículo científico publicado en 2013

Enhanced HIV-1 neutralization by antibody heteroligation

artículo científico publicado en 2012

HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.

artículo científico publicado en 2014

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

scientific article published on 24 October 2012

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

article

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

scientific article published on 01 August 2019

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

artículo científico publicado en 2016

HIV-specific B cell response in patients with broadly neutralizing serum activity

artículo científico publicado en 2015

Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness

artículo científico publicado en 2010

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

artículo científico publicado en 2011

Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160Δc(BaL.).

scientific article published on 13 September 2013

Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses

artículo científico publicado en 2011

Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies

artículo científico publicado en 2013

Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo

artículo científico publicado en 2017

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

artículo científico publicado en 2010

Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs

artículo científico publicado en 2013

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

artículo científico publicado en 2011

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

artículo científico publicado en 2013

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

artículo científico publicado en 2010

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

artículo científico publicado en 2015

Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody

artículo científico publicado en 2013

Structural basis for germline antibody recognition of HIV-1 immunogens

artículo científico publicado en 2016

Structural insights on the role of antibodies in HIV-1 vaccine and therapy

artículo científico publicado en 2014

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

artículo científico publicado en 2015

Lista de obras de

A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo

A method for identification of HIV gp140 binding memory B cells in human blood

A robust pipeline for rapid production of versatile nanobody repertoires

Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient

Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity

Antibodies in HIV-1 vaccine development and therapy

Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike

Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG Binding ⬇️

Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein

Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission

CD4-binding-Site Recognition by VH1-46 Germline-derived HIV-1 Neutralizers.

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs.

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies

Enhanced HIV-1 neutralization by antibody heteroligation

HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

HIV-specific B cell response in patients with broadly neutralizing serum activity

Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160Δc(BaL.).

Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses

Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies

Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody

Structural basis for germline antibody recognition of HIV-1 immunogens

Structural insights on the role of antibodies in HIV-1 vaccine and therapy

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.